155 related articles for article (PubMed ID: 9463174)
21. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
Di Salvo MM; Ardita G; Giani L; Mugno F; Stevenazzi F; Mazzone A
Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
[TBL] [Abstract][Full Text] [Related]
22. [The long-term results and indications for use of Gore-Texgrafts in the femoropopliteal position in patients with atherosclerotic lesion of lower limb arteries].
Pokrovskiĭ AV; Dan VN; Zotikov AE; Chupin AV; Shubin AA; Chikharev MV
Angiol Sosud Khir; 2004; 10(2):91-7. PubMed ID: 15163976
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of surgical results in lower limb atherosclerotic ischemia comparing men and women].
Zawilski J; Majewski W; Chmielecki J
Pol Tyg Lek; 1992 May 4-11; 47(18-19):395-7. PubMed ID: 1409050
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of cutaneous necrosis risk in peripheral arterial diseases].
D'Eri A; Martini R; Cordova RM; Trevisan G; Andreozzi GM
Minerva Cardioangiol; 2002 Jun; 50(3):239-44. PubMed ID: 12107403
[TBL] [Abstract][Full Text] [Related]
26. Double-blind controlled study of the efficacy and pharmacological properties of heparan sulfate in patients with occlusive arterial disease of the lower limbs.
Strano A; Pinto A; Galati D
Drugs Exp Clin Res; 1990; 16(10):543-50. PubMed ID: 2151628
[TBL] [Abstract][Full Text] [Related]
27. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.
Matoba S; Tatsumi T; Murohara T; Imaizumi T; Katsuda Y; Ito M; Saito Y; Uemura S; Suzuki H; Fukumoto S; Yamamoto Y; Onodera R; Teramukai S; Fukushima M; Matsubara H;
Am Heart J; 2008 Nov; 156(5):1010-8. PubMed ID: 19061721
[TBL] [Abstract][Full Text] [Related]
28. Popliteal artery aneurysms. Factors associated with thromboembolism and graft failure.
Martelli E; Ippoliti A; Ventoruzzo G; De Vivo G; Ascoli Marchetti A; Pistolese GR
Int Angiol; 2004 Mar; 23(1):54-65. PubMed ID: 15156131
[TBL] [Abstract][Full Text] [Related]
29. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency].
Cappelli R; Bicchi M; Arrigucci S; Boschi S; Guerrini M; Forconi S
Minerva Cardioangiol; 1999 Mar; 47(3):81-8. PubMed ID: 10389449
[TBL] [Abstract][Full Text] [Related]
30. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
31. [Long-term sequelae of deep venous thrombosis of the legs. Experience with mesoglycan].
Prandoni P; Cattelan AM; Carta M
Ann Ital Med Int; 1989; 4(4):378-85. PubMed ID: 2535067
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
33. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
34. Short-term and long-term effects of one-week treatment with intravenous iloprost in critical limb ischemia patients (Leriche-Fontaine stage III and IV).
Meini S; De Franco V; Auteri A; Setacci C; Di Renzo M; Pieragalli D
Int Angiol; 2005 Mar; 24(1):64-9. PubMed ID: 15877001
[TBL] [Abstract][Full Text] [Related]
35. Functional outcome of distal bypasses for lower limb ischemia.
Kukkonen T; Junnila J; Tulla H; Aittola V; Mäkinen K
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):258-61. PubMed ID: 16293426
[TBL] [Abstract][Full Text] [Related]
36. [Misoprostol--oral prostanoid--the first clinical trial for use in patients with peripheral vascular disease].
Goszcz A; Grodzińska L; Kostka-Trabka E; Bieroń K; Sławiński M; Jachym R; Ochmański W
Przegl Lek; 1997; 54(7-8):505-9. PubMed ID: 9480458
[TBL] [Abstract][Full Text] [Related]
37. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
Arosio E; Sardina M; Prior M; De Marchi S; Zannoni M; Bianchini C
Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
[TBL] [Abstract][Full Text] [Related]
38. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
39. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms.
Shoemaker RC; House DE
Neurotoxicol Teratol; 2006; 28(5):573-88. PubMed ID: 17010568
[TBL] [Abstract][Full Text] [Related]
40. Quality of live as measured by the CIVQ 20. Questionnaire following oral mesoglycan treatment of patients with chronic venous disease.
Allegra C; Antignani PL
Int Angiol; 2014 Oct; 33(5):407-18. PubMed ID: 24566500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
